Evidence map›Paper›PMID 35886599›Full record

ArticleInternational journal of environmental research and public health2022

Adolescents, Young Adults, and Adults Continue to Use E-Cigarette Devices and Flavors Two Years after FDA Discretionary Enforcement.

Devin M McCauley, Shivani Mathur Gaiha, Lauren Kass Lempert, Bonnie Halpern-Felsher

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Appeal and Sensory Characteristics of Oral Nicotine Products in Young Adults Who Vape E-Cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Trial
  2. On the Detection and Scope of "Third-Hand Vaping": A Critical Review of the Literature.International journal of environmental research and public health · 2026
    Review
  3. Racial and/or Ethnic, Sex, and Age Differences in Smoking Prevalences Among Youth and Young Adults.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Gaps in Awareness of the United States Minimum Legal Age of E-Cigarette and Cigarette Sales: Implications for Public Health Messaging.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. A Patchy Prohibition: Product and Flavor Substitution After the Food and Drug Administration's Prioritized Enforcement Policy on Flavored E-cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Devin M McCauleyReach Lab, Department of Pediatrics, Division of Adolescent Medicine, Stanford University, Palo Alto, CA 94304, USA.ORCID 0000-0002-0794-9433
Shivani Mathur GaihaReach Lab, Department of Pediatrics, Division of Adolescent Medicine, Stanford University, Palo Alto, CA 94304, USA.
Lauren Kass LempertReach Lab, Department of Pediatrics, Division of Adolescent Medicine, Stanford University, Palo Alto, CA 94304, USA.
Bonnie Halpern-FelsherReach Lab, Department of Pediatrics, Division of Adolescent Medicine, Stanford University, Palo Alto, CA 94304, USA.ORCID 0000-0001-9276-1322

Funding

PROJECT 5: IMPACT OF CHANGING TOBACCO PRODUCT USE ON HEALTHCARE COSTS FOR GENERAL AND VULNERABLE POPULATIONSU54HL147127 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLANTZ, STANTON ARNOLD · 2018 to 2022
$20.4M
Countering E-cigarette Marketing in the Retail Environment among Adolescents and Young AdultsK99CA267477 · NCI · STANFORD UNIVERSITY · PI GAIHA, SHIVANI MATHUR · 2021 to 2023
$442k
National Cancer Institute of the National Institutes of Health K99CA267477NCI NIH HHS K99 CA267477NHLBI NIH HHS U54 HL147127
6 · The paper itself

Abstract

This study assesses the use of e-cigarette devices and flavors using a large, cross-sectional survey of adolescents, young adults, and adults (N = 6131; ages 13−40 years old; Mage = 21.9) conducted from November to December 2021, 22 months after the FDA announced its prioritized enforcement policy against some flavored pod/cartridge-based e-cigarettes. We analyzed the patterns of use by age group: adolescents and young adults (AYAs) under 21 (minimum age of e-cigarette sales), young adults (21−24 years old), and adults (25−40 years old). The participants reported using e-cigarettes ever (44.2% < 21; 67.1% 21−24; 58.0% > 24), in the past 30 days (29.8% < 21; 52.6% 21−24; 43.3% > 24), and in the past 7 days (24.5% < 21; 43.9% 21−24; 36.5% > 24). Disposables were the most used e-cigarette device type across age groups (39.1% < 21; 36.9% 21−24; 34.5% > 24). Fruit, sweet, mint, and menthol flavors were popular across age groups; however, chi-squared tests for trends in proportions revealed age-related trends in past 30-day flavor use by device type. Findings suggest current AYA e-cigarette use may be higher than recorded by the NYTS 2021. The FDA, states, and localities should adopt more comprehensive restrictions on flavored e-cigarette products in order to reduce adolescent and young adult e-cigarette use.

Indexed as

Electronic Nicotine Delivery SystemsTobacco ProductsVapingAdolescentAdultCommerceCross-Sectional StudiesFlavoring AgentsHumansYoung AdultFlavoring Agentsadolescentsadultse-cigarette devicese-cigarettesflavorsFood and Drug Administrationmentholyoung adults

Identifiers

PMID35886599
PMCPMC9322506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.